▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

MedTech companies are accelerating innovation in China, where public hospitals play a pivotal role. These hospitals employ 64% of licensed doctors, manage 82% of inpatient admissions, and handle 40% of ambulatory visits, accounting for nearly half of the country's total health expenditure.

This central role also contributes to China's unique approach to regulating medical service prices. Unlike many developed markets, public hospitals in China must adhere to the provincial medical service price catalog in order to offer and bill for treatments. While private hospitals have more flexibility to set their own prices, they often align with these standards to qualify as BMI-designated institutions and remain competitive.

For new technologies that fill clinical gaps, simplify complex procedures, or offer innovative treatments, securing a spot in a provincial medical service price catalog with optimized pricing is critical for success in China’s inpatient and outpatient markets.

In this 45-minute video course, you’ll learn how China’s medical service pricing reform impacts:

• Pricing and commercialization of innovative medical technologies
• Value-based approval and pricing trends shaping market access
• Strategic growth opportunities tied to emerging policy directions
• Practical planning tools to strengthen policy monitoring and implementation, including provincial policy summaries and guides